Chlorogenic Acid Functions as a Novel Agonist of PPARγ2 during the Differentiation of Mouse 3T3-L1 Preadipocytes

Rosiglitazone (RG) is a well-known activator of peroxisome proliferator-activated receptor-gamma (PPARγ) and used to treat hyperglycemia and type 2 diabetes; however, its clinical application has been confounded by adverse side effects. Here, we assessed the roles of chlorogenic acid (CGA), a phenol...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Shu-guang, Pang, Yi-lin, Zhu, Qi, Kang, Jing-he, Liu, Ming-xin, Wang, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304673/
https://www.ncbi.nlm.nih.gov/pubmed/30627576
http://dx.doi.org/10.1155/2018/8594767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304673/
https://www.ncbi.nlm.nih.gov/pubmed/30627576
http://dx.doi.org/10.1155/2018/8594767

Ejemplares similares